Literature DB >> 11512422

[Functioning, comorbidity and treatment of 141 adults with attention deficit hyperactivity disorder (ADHD) at a psychiatric outpatient department].

J J Kooij1, L P Aeckerlin, J K Buitelaar.   

Abstract

OBJECTIVE: To describe the functioning, comorbidity and treatment of adults with attention deficit hyperactivity disorder (ADHD).
DESIGN: Retrospective.
METHOD: In the period 1 May 1995 to 31 January 1998, 141 patients aged 18-54 were diagnosed with ADHD at the Delfland Psychiatric Outpatients' Department, Delft, the Netherlands. For all of these patients, data concerning the functioning, comorbidity, and the response to treatment with clonidine (n = 34) or methylphenidate (n = 99), were collected from anamneses, hetero-anamneses and school reports.
RESULTS: The most frequent complaints were: mood-swings, rage-outbursts, sensation-seeking behaviour, sleeping disorders, anxiety and depressive symptoms. In 94% (n = 123) of the cases, childhood onset of ADHD symptoms was confirmed by a family member. The distribution of ADHD subtypes was comparable to the distribution in children. Psychiatric comorbidity was common. Treatment with methylphenidate was more effective and better tolerated than treatment with clonidine.
CONCLUSION: With respect to ADHD subtypes, patterns of comorbidity and effectiveness of medication, ADHD in the adults studied was comparable with what is known about ADHD in children.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11512422

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  6 in total

Review 1.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630

2.  Sleep in adults with attention deficit hyperactivity disorder (ADHD) before and during treatment with methylphenidate: a controlled polysomnographic study.

Authors:  Esther Sobanski; Michael Schredl; Nina Kettler; Barbara Alm
Journal:  Sleep       Date:  2008-03       Impact factor: 5.849

3.  Dream recall and dream content in children with attention deficit/hyperactivity disorder.

Authors:  Michael Schredl; Heiko Sartorius
Journal:  Child Psychiatry Hum Dev       Date:  2010-04

4.  Test of variables of attention (TOVA) as a predictor of early attention complaints, an antecedent to dementia.

Authors:  Eric R Braverman; Amanda Lih-Chuan Chen; Thomas J H Chen; John D Schoolfield; Alison Notaro; Dasha Braverman; Mallory Kerner; Seth H Blum; Vanessa Arcuri; Michael Varshavskiy; Uma Damle; B William Downs; Roger L Waite; Marlene Oscar-Berman; John Giordano; Kenneth Blum
Journal:  Neuropsychiatr Dis Treat       Date:  2010-10-15       Impact factor: 2.570

5.  Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature.

Authors:  Ylva Ginsberg; Javier Quintero; Ernie Anand; Marta Casillas; Himanshu P Upadhyaya
Journal:  Prim Care Companion CNS Disord       Date:  2014-06-12

6.  Rates of undiagnosed attention deficit hyperactivity disorder in London drug and alcohol detoxification units.

Authors:  Zoe Huntley; Stefanos Maltezos; Charlotte Williams; Alun Morinan; Amy Hammon; David Ball; E Jane Marshall; Francis Keaney; Susan Young; Patrik Bolton; Karen Glaser; Raoul Howe-Forbes; Jonna Kuntsi; Kiriakos Xenitidis; Declan Murphy; Philip J Asherson
Journal:  BMC Psychiatry       Date:  2012-12-06       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.